Ultrase® MT20
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Forest Laboratories
Overview
Ultrase® MT20 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Ultrase® MT20 clinical trials
Explore related
Medical disclaimer. This page summarizes research about Ultrase® MT20 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.